PBS

The Iran war may disrupt access to medicines

While PBS stock‑holding rules provide a buffer against short disruptions, experts warn that prolonged conflict in the Middle East could…

Year in review: Dementia breakthroughs

Dementia has surpassed heart disease to become the leading cause of death in Australia, a statistic confirmed by the Australian…

No PBS for new Alzheimer’s therapy

The Pharmaceutical Benefits Advisory Committee has rejected an application for a newly approved Alzheimer’s treatment to be included on the…

Labor pledges to protect PBS from cuts

Last week, President Donald Trump wrote to 17 major pharmaceutical companies in the US demanding they lower their prices for…

Do pharmaceutical tariffs threaten the PBS?

There are fears that, if implemented, the tariffs could cost the Australian economy up to $2.8 bn. That’s both in…

‘Major win’: Albanese promises to cap cost of PBS medications

Prescription medicines will be capped at $25 per script under a major cost-of-living election promise set to be unveiled by…